Skip to main content
Premium Trial:

Request an Annual Quote

Fitch Assigns BBB Rating to Quest's Senior Notes Offering

NEW YORK (GenomeWeb) – Fitch Ratings has assigned a BBB rating to the $1.2 billion senior notes offering announced today by Quest Diagnostics. 

Fitch also said the rating outlook is stable. It said in a statement that the refinancing will raise Quest's debt leverage this year to be temporarily elevated but that it anticipates the debt to be repaid and Quest's total debt balances to be reduced to about $3.8 billion by the end of the year. 

Quest said that it will use the proceeds from the offering to fund the purchase of up to $250 million in combined aggregate principal amount of its 6.95 percent senior notes due 2037 and its 5.75 percent senior notes due 2040. In addition, it intends to redeem all $500 million of its outstanding 5.45 percent senior notes due 2015; all $375 million of its outstanding 6.4 percent senior notes due 2017; and $150 million, or 50 percent, of its outstanding 3.2 percent senior notes due 2016.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.